Rite Aid Corp. is streamlining its operations as part of an ongoing bankruptcy case, leading to the closure of multiple locations nationwide. Recent filings reveal additional closures, including several stores in Oregon and southwest Washington.
Eli Lilly is exempting Arkansas from its new 340B contract pharmacy restrictions due to Arkansas state law.
Novo Nordisk announced on its website it will discontinue Levemir in the U.S. by the end of 2024.
A South Carolina federal judge stuck down the HRSA definition of "patient" in the 340B program, a federal program designed to provide discounts on prescription drugs. Chief Judge R. Bryan Harwell, in the case of Genesis Health Care v. Becerra, ruled that the 340B statute does not require a healthcare service to be initiated before a prescription filled with a 340B drug can qualify under the program.
The 340B Drug Pricing Program is managed by the Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA). For more information visit: www.hrsa.gov/opa This material is provided for general informational purposes of 340B Drug Prices only and is not an endorsement of any prescription product referenced herein. For information as to the clinical use or efficacy of a referenced product, please contact the manufacturer. 340B Price Guide makes no representations and provides no warranties as to the effectiveness or suitability for use of any prescription product referenced herein. Any referenced cost is provided as an estimate only and the actual cost is subject to change at any time and without notice. 340B Price Guide does not guarantee that the cost represented herein will be the actual and pharmacy shall at all times collect amounts due as indicated at the time of adjudication and shall be reimbursed per the terms of its agreement.'